Featured Research

from universities, journals, and other organizations

Pain Relievers Appear Ineffective In Preventing Alzheimer's In The Very Elderly

Date:
April 23, 2009
Source:
Group Health Cooperative Center for Health Studies
Summary:
A new study shows that nonsteroidal anti-inflammatory drugs (NSAIDs), such as the pain relievers ibuprofen and naproxen, do not prevent Alzheimer's disease or other forms of dementia. In addition, the risk of developing dementia in the study's very elderly population (most were over age 83 when they developed dementia) was 66 percent higher among heavy NSAID users than among people who used little or no NSAIDs.

A new study shows that nonsteroidal anti-inflammatory drugs (NSAIDs), such as the pain relievers ibuprofen and naproxen, do not prevent Alzheimer's disease or other forms of dementia. Instead, the risk of developing dementia in the study's very elderly population (most were over age 83 when they developed dementia) was 66 percent higher among heavy NSAID users than among people who used little or no NSAIDs, according to research published online in Neurology, the medical journal of the American Academy of Neurology.

Researchers identified 2,736 members of Group Health, an integrated healthcare delivery system, who did not have dementia when they enrolled in the study at an average age of 75. The investigators then followed these people for 12 years to see if they developed Alzheimer's or other forms of dementia. They checked Group Health pharmacy records for NSAIDs (tracking both prescriptions and over-the-counter use) and also asked participants about their use of NSAIDs.

Of the participants, 351 people had a history of using NSAIDs heavily at the study's start, and another 107 became heavy NSAID users during the follow-up period. Heavy use was defined as having prescriptions for NSAIDs at least 68 percent of the time in two years.

During the study, 476 people developed Alzheimer's disease or dementia. The risk of developing dementia among heavy NSAID users was 66 percent higher than among people with little or no NSAID use.

"NSAIDs are useful for relieving pain from conditions including arthritis," said study author Eric B. Larson, MD, MPH, executive director of Group Health Center for Health Studies. "Although we hoped to find a protective effect, there was none. Thus, for this age group, there's no basis for taking NSAIDs to prevent Alzheimer's disease. Our study in this quite elderly population showed more risk of dementia with NSAIDs, especially when used heavily."

The study suggests a need to re-interpret earlier findings that suggested NSAIDs can prevent or delay the disease. Why the discrepancy?

"A key difference between this study and most of those done earlier is that our participants were older," said lead study author John C. S. Breitner, MD, MPH, University of Washington professor of psychiatry and head of the Division of Geriatric Psychiatry at the VA Puget Sound Health Care System. "It has been argued for some time that NSAID use delays the onset of Alzheimer's disease. If so, studies of younger NSAID users would show fewer Alzheimer's cases, while groups of older people might show more cases, including those that would have happened earlier if they had not been delayed."

"This is one interpretation of the results, but other explanations are possible," cautioned Breitner. "We must not ignore our main finding: increased risk of dementia in the NSAID users. We need further research to understand that more clearly."

The U.S. Department of Veterans Affairs, the National Institutes of Health, and the Paul B. Beeson Career Development Awards in Aging Research Program supported the study.


Story Source:

The above story is based on materials provided by Group Health Cooperative Center for Health Studies. Note: Materials may be edited for content and length.


Journal Reference:

  1. J. C.S. Breitner, S. J.P.A. Haneuse, R. Walker, S. Dublin, P. K. Crane, S. L. Gray, and E. B. Larson. Risk of dementia and AD with prior exposure to NSAIDs in an elderly community-based cohort. Neurology, 2009; (in press) DOI: 10.1212/WNL.0b013e3181a18691

Cite This Page:

Group Health Cooperative Center for Health Studies. "Pain Relievers Appear Ineffective In Preventing Alzheimer's In The Very Elderly." ScienceDaily. ScienceDaily, 23 April 2009. <www.sciencedaily.com/releases/2009/04/090422175148.htm>.
Group Health Cooperative Center for Health Studies. (2009, April 23). Pain Relievers Appear Ineffective In Preventing Alzheimer's In The Very Elderly. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2009/04/090422175148.htm
Group Health Cooperative Center for Health Studies. "Pain Relievers Appear Ineffective In Preventing Alzheimer's In The Very Elderly." ScienceDaily. www.sciencedaily.com/releases/2009/04/090422175148.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins